Identification of copy number variants on human chromosome 22 in patients with a variety of clinical findings

Cytogenetic and Genome Research

Volumn 134, Issue 4, 2011, Pages 260-268

  Yu, S ^a   Graf, W D ^b   Ramalingam, A ^a   Brawner, S J ^a   Joyce, J M ^a   Fiedler, S ^a   Zhou, X G ^a,c   Liu, H Y ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Chromosomal microarray analysis; Chromosome 22; Copy number variant; Deletion; Duplication; Genomic disorders; Low copy repeat

Indexed keywords

ARTICLE; CHILD; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME REARRANGEMENT; CLINICAL FEATURE; COPY NUMBER VARIATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 22; COHORT STUDIES; FEMALE; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENETIC ASSOCIATION STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; POLYMERASE CHAIN REACTION;

EID: 80052003309     PISSN: 14248581     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000330123     Document Type: Article

References (53)

1. Abo-Dalo B, Kutsche K, Mautner V, Kluwe L: Large intragenic deletions of the NF2 gene: Breakpoints and associated phenotypes. Genes Chromosomes Cancer 49: 171-175 (2010).
2. Ballif BC, Yu W, Shaw CA, Kashork CD, Shaffer LG: Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions. Hum Mol Genet 12: 2153-2165 (2003). (Pubitemid 37098986)
3. Ballif BC, Hornor SA, Jenkins E, Madan-Khetarpal S, Surti U, et al: Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat Genet 39: 1071-1073 (2007). (Pubitemid 47340655)
4. Belien V, Gerard-Blanluet M, Serero S, Le Du N, Baumann C, et al: Partial trisomy of chromosome 22 resulting from a supernumerary marker chromosome 22 in a child with features of cat eye syndrome. Am J Med Genet A 146A:1871-1874 (2008). (Pubitemid 352000729)
5. Ben-Shachar S, Ou Z, Shaw CA, Belmont JW, Patel MS, et al: 22q11.2 distal deletion: A recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 82: 214-221 (2008). (Pubitemid 351726089)
6. Berends MJ, Tan-Sindhunata G, Leegte B, van Essen AJ: Phenotypic variability of cat-eye syndrome. Genet Couns 12: 23-34 (2001). (Pubitemid 32244702)
7. Berg JS, Potocki L, Bacino CA: Common recurrent microduplication syndromes: Diagnosis and management in clinical practice. Am J Med Genet A 152A:1066-1078 (2010).
8. Bittel DC, Yu S, Newkirk H, Kibiryeva N, Holt A 3rd, et al: Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet Genome Res 124: 113-120 (2009).
9. Brunet A, Armengol L, Heine D, Rosell J, Garcia-Aragones M, et al: BAC array CGH in patients with velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1. BMC Med Genet 10: 144 (2009).
10. Cole CG, McCann OT, Collins JE, Oliver K, Willey D, et al: Finishing the finished human chromosome 22 sequence. Genome Biol 9:R78 (2008).
11. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, et al: Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712 (2009).
12. Coppinger J, McDonald-McGinn D, Zackai E, Shane K, Atkin JF, et al: Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region. Hum Mol Genet 18: 1377-1383 (2009).
13. D'Angelo CS, Jehee FS, Koiffmann CP: An inherited atypical 1 Mb 22q11.2 deletion within the DGS/VCFS 3 Mb region in a child with obesity and aggressive behavior. Am J Med Genet A 143A:1928-1932 (2007). (Pubitemid 47206073)
14. Descartes M, Franklin J, de Stahl TD, Piotrowski A, Bruder CE, et al: Distal 22q11.2 microduplication encompassing the BCR gene. Am J Med Genet A 146A:3075-3081 (2008). (Pubitemid 352774649)
15. de Smith AJ, Walters RG, Coin LJ, Steinfeld I, Yakhini Z, et al: Small deletion variants have stable breakpoints commonly associated with Alu elements. PLoS One 3:e3104 (2008).
16. Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, et al: The DNA sequence of human chromosome 22. Nature 402: 489-495 (1999).
17. Ensenauer RE, Adeyinka A, Flynn HC, Michels VV, Lindor NM, et al: Microduplication 22q11.2, an emerging syndrome: Clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 73: 1027-1040 (2003). (Pubitemid 37414217)
18. Fernandez L, Nevado J, Santos F, Heine-Suner D, Martinez-Glez V, et al: A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review. BMC Med Genet 10: 48 (2009).
19. Foley P, Bunyan D, Stratton J, Dillon M, Lynch SA: Further case of Rubinstein-Taybi syndrome due to a deletion in EP300. Am J Med Genet A 149A:997-1000 (2009).
20. Gauthier J, Spiegelman D, Piton A, Lafreniere RG, Laurent S, et al: Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet 150B:421-424 (2009).
21. Gothelf D, Frisch A, Michaelovsky E, Weizman A, Shprintzen RJ: Velo-cardio-facial syndrome. J Ment Health Res Intellect Disabil 2: 149-167 (2009).
22. Gu W, Zhang F, Lupski JR: Mechanisms for human genomic rearrangements. Pathogenetics 1: 4 (2008).
23. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, et al: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66: 947-956 (2009).
24. Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A: Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27: 293-298 (2001). (Pubitemid 32201850)
25. Guris DL, Duester G, Papaioannou VE, Imamoto A: Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev Cell 10: 81-92 (2006). (Pubitemid 43025679)
26. Hannes F, Vermeesch JR: Benign and pathogenic copy number variation on the short arm of chromosome 4. Cytogenet Genome Res 123: 88-93 (2008).
27. Hastings PJ, Ira G, Lupski JR: A microhomologymediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327 (2009).
28. Hierck BP, Molin DG, Boot MJ, Poelmann RE, Gittenberger-de Groot AC: A chicken model for DGCR6 as a modifier gene in the Di-George critical region. Pediatr Res 56: 440-448 (2004). (Pubitemid 39128831)
29. Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, et al: High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet 122: 117-127 (2007). (Pubitemid 47241777)
30. Kidd JM, Graves T, Newman TL, Fulton R, Hayden HS, et al: A human genome structural variation sequencing resource reveals insights into mutational mechanisms. Cell 143: 837-847 (2010).
31. Koolen DA, Reardon W, Rosser EM, Lacombe D, Hurst JA, et al: Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation. Eur J Hum Genet 13: 1019-1024 (2005). (Pubitemid 43073608)
32. Kurahashi H, Tsuda E, Kohama R, Nakayama T, Masuno M, et al: Another critical region for deletion of 22q11: A study of 100 patients. Am J Med Genet 72: 180-185 (1997). (Pubitemid 27426083)
33. Lafay-Cousin L, Payne E, Strother D, Chernos J, Chan M, Bernier FP: Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor. Am J Med Genet A 149A:2855-2859 (2009).
34. Lee C, Iafrate AJ, Brothman AR: Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 39:S48-S54 (2007). (Pubitemid 47014476)
35. Liehr T, Mrasek K, Weise A, Dufke A, Rodriguez L, et al: Small supernumerary marker chromosomes-progress towards a genotypephenotype correlation. Cytogenet Genome Res 112: 23-34 (2006). (Pubitemid 41579452)
36. Luciani JJ, de Mas P, Depetris D, Mignon-Ravix C, Bottani A, et al: Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: Cytogenetic, molecular, and clinical analyses of 32 new observations. J Med Genet 40: 690-696 (2003). (Pubitemid 37100703)
37. Lupski JR: Structural variation in the human genome. N Engl J Med 356: 1169-1171 (2007). (Pubitemid 46425604)
38. Makoff AJ, Flomen RH: Detailed analysis of 15q11-q14 sequence corrects errors and gaps in the public access sequence to fully reveal large segmental duplications at breakpoints for Prader-Willi, Angelman, and inv dup(15) syndromes. Genome Biol 8:R114 (2007).
39. Masukawa H, Ozaki T, Nogimori T: Cat eye syndrome with hypogonadotropic hypogonadism. Intern Med 37: 853-856 (1998). (Pubitemid 28550635)
40. McDermid HE, Morrow BE: Genomic disorders on 22q11. Am J Hum Genet 70: 1077-1088 (2002). (Pubitemid 34450561)
41. Mefford HC, Eichler EE: Duplication hotspots, rare genomic disorders, and common disease. Curr Opin Genet Dev 19: 196-204 (2009).
42. Mills RE, Walter K, Stewart C, Handsaker RE, Chen K, et al: Mapping copy number variation by population-scale genome sequencing. Nature 470: 59-65 (2011).
43. Pfuhl T, Durr M, Spurk A, Schwalbert B, Nord R, et al: Biochemical characterisation of the proteins encoded by the DiGeorge critical region 6 (DGCR6) genes. Hum Genet 117: 70-80 (2005). (Pubitemid 40778784)
44. Phelan MC: Deletion 22q13.3 syndrome. Orphanet J Rare Dis 3: 14 (2008).
45. Portnoï MF: Microduplication 22q11.2: A new chromosomal syndrome. Eur J Med Genet 52: 88-93 (2009).
46. Samuels IS, Saitta SC, Landreth GE: MAP'ing CNS development and cognition: An ERKsome process. Neuron 61: 160-167 (2009).
47. Shaikh TH, O'Connor RJ, Pierpont ME, Mc-Grath J, Hacker AM, et al: Low copy repeats mediate distal chromosome 22q11.2 deletions: Sequence analysis predicts breakpoint mechanisms. Genome Res 17: 482-491 (2007). (Pubitemid 46556452)
48. Trabacca A, Losito L, De Rinaldis M, Gennaro L: Congenital hypotonia in a child with a de novo 22q13 monosomy and 2pter duplication: A clinical and molecular genetic study. J Child Neurol 26: 235-238 (2011).
49. Willis A, Bender HU, Steel G, Valle D: PRODH variants and risk for schizophrenia. Amino Acids 35: 673-679 (2008).
50. Wilson HL, Wong AC, Shaw SR, Tse WY, Stapleton GA, et al: Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 40: 575-584 (2003). (Pubitemid 37046910)
51. Yu S, Bittel DC, Kibiryeva N, Zwick DL, Cooley LD: Validation of the Agilent 244K oligonucleotide array-based comparative genomic hybridization platform for clinical cytogenetic diagnosis. Am J Clin Pathol 132: 349-360 (2009a).
52. Yu S, Kielt M, Stegner AL, Kibiryeva N, Bittel DC, Cooley LD: Quantitative real-time polymerase chain reaction for the verification of genomic imbalances detected by microarray-based comparative genomic hybridization. Genet Test Mol Biomarkers 13: 751-760 (2009b).
53. Yu S, Fiedler S, Stegner A, Graf WD: Genomic profile of copy number variants on the short arm of human chromosome 8. Eur J Hum Genet 18: 1114-1120 (2010).